Cerebral amyloid angiopathy
Cerebral amyloid angiopathy (CAA) is a neurological condition characterized by the accumulation of amyloid proteins in the walls of the blood vessels in the brain. This condition is often associated with Alzheimer's disease and other neurodegenerative disorders.
Etiology[edit | edit source]
The exact cause of CAA is unknown. However, it is believed to be related to the abnormal processing of amyloid precursor protein (APP), which leads to the accumulation of amyloid proteins in the brain's blood vessels. This process is similar to the one observed in Alzheimer's disease, where amyloid plaques accumulate in the brain tissue.
Pathophysiology[edit | edit source]
In CAA, amyloid proteins accumulate in the walls of the small to medium-sized blood vessels in the brain, leading to vessel wall thickening and reduced blood flow. This can result in microbleeds, microinfarcts, and, in severe cases, intracerebral hemorrhage. The most commonly involved protein is amyloid beta, the same protein involved in the formation of amyloid plaques in Alzheimer's disease.
Clinical Presentation[edit | edit source]
The clinical presentation of CAA can vary widely. Some individuals may remain asymptomatic, while others may present with cognitive impairment, dementia, stroke, or intracerebral hemorrhage. The risk of developing symptoms increases with age.
Diagnosis[edit | edit source]
Diagnosis of CAA is often challenging due to its nonspecific symptoms and the lack of definitive diagnostic tests. It is often diagnosed based on clinical presentation, neuroimaging findings, and, in some cases, brain biopsy. The Boston criteria is commonly used to diagnose CAA.
Treatment[edit | edit source]
There is currently no cure for CAA. Treatment is primarily focused on managing symptoms and preventing complications, such as stroke and intracerebral hemorrhage. This may involve the use of antihypertensive medications, anticoagulants, and statins.
Prognosis[edit | edit source]
The prognosis of CAA varies depending on the severity of the condition and the presence of complications. In severe cases, CAA can lead to significant disability and death.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD